LifeVantage Corporation (NASDAQ: LFVN) will release its financial results for the fourth quarter and full fiscal year ended June 30, 2026, after the US stock market closes on Thursday, August 27, 2026.

The Salt Lake City-based health and wellness company, which markets products designed to activate cellular health processes, scheduled a conference call for investors at 2:30 pm Mountain Time (4:30 pm Eastern Time) on the same day.

Conference Call Details

Investors can participate in the live call by dialing (877) 704-4453 from the US or (201) 389-0920 for international callers. A telephone replay will be available approximately two hours after the call concludes and will remain accessible through Thursday, September 17, 2026.

Replay access details:

• US callers: Dial (844) 512-2921 with confirmation code 13761673
• International callers: Dial (412) 317-6671 with confirmation code 13761673

A simultaneous live webcast will be available on the Investor Relations section of the company’s website. The webcast will be archived for approximately 30 days.

About LifeVantage

LifeVantage describes itself as a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds can unlock genetic health potential. Its product line includes the flagship Protandim family of products, TrueScience Liquid Collagen, MindBody GLP-1 System, and P84 gut activator.

The company also offers activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System, alongside AXIO nootropic energy drink mixes, TrueScience skin and hair care products, and Petandim pet supplements.

Founded in 2003 and headquartered in Lehi, Utah, LifeVantage sells its products through independent consultants who share the business opportunity with entrepreneurs.

LifeVantage Corporation has granted a total of 848,767 shares in equity awards to Terrence Moorehead, its newly appointed President and Chief Executive Officer, as an inducement material to his employment. The Board of Directors approved the awards on August 6, 2026, under the company’s 2026 New Employee Long-Term Incentive Plan, complying with Nasdaq Listing Rule 5635(c)(4). The move aligns executive compensation with long-term shareholder value through service-based and performance-based vesting conditions.

The award structure consists of two distinct components designed to retain leadership while driving specific financial outcomes. The first component comprises time-based restricted stock units (RSUs), while the second involves performance-based restricted stock units (PSUs) linked to operational targets. Both awards are subject to continued service with the company through their respective vesting dates.

Award Structure Details

The following table outlines the composition and vesting terms of the equity grants awarded to Mr. Moorehead:

The RSUs will vest in three equal annual installments beginning on the one-year anniversary of the August 6, 2026 grant date. This time-based vesting ensures retention over a three-year horizon regardless of short-term market fluctuations.

The PSUs carry higher potential value but are contingent upon achieving specific financial milestones. These units will vest over a three-year period based on the achievement of certain revenue and Adjusted EBITDA margin targets. This performance linkage ties a significant portion of the executive’s compensation directly to the company’s profitability and top-line growth objectives.

What the Numbers Show

The composition of the award reveals a strategic emphasis on performance-driven compensation. The PSUs represent approximately 64% of the total share count granted (540,123 out of 848,767 shares), indicating that the Board prioritizes meeting revenue and margin goals over simple tenure-based retention. By weighting the majority of the equity toward performance metrics, LifeVantage signals that future executive rewards are heavily dependent on delivering measurable improvements in Adjusted EBITDA margins and revenue growth.

LifeVantage Corporation (NASDAQ: LFVN) operates as an activation company focused on nutrigenomics, offering scientifically validated activators including the Protandim family of products, TrueScience Liquid Collagen, and the MindBody GLP-1 System. The company was founded in 2003 and is headquartered in Lehi, Utah.